In breast cancer, cancer cells induce production of CCL5 (also called RANTES) from MSCs via interacting with CCR5, increasing cancer cell motility, invasion, and metastasis in vitro and in vivo [60]. The gene discussed is CCL5; the disease is breast carcinoma.